AwardedSVKGoods€44,264
Antineoplastické a imunomodulačné činidlá
- Published
- Published 10 February 2025
- Deadline
- Closed 31 March 2025
Overview
Univerzitná nemocnica Martin procured antineoplastic and immunomodulatory agents divided into 64 separate lots, with bidders able to submit offers for individual lots or combinations thereof. The contract was awarded on 30 April 2026 to five suppliers: BAX PHARMA, INTRAVENA, MED-ART, PHOENIX Zdravotnícke zásobovanie, and UNIPHARMA, for a total value of 8,406,960.52 EUR.
Key details
- Country
- SVK
- Status
- Awarded
- Category
- Goods
- Estimated value
- €44,264
- Procedure
- Open
- SME suitable
- Yes
- Published
- 10 February 2025
- Deadline
- Closed
Antineoplastic agents
Award outcome
- Awarded value
- €8,406,961
- Award date
- 30 April 2026
- Contract period
- — → 19 April 2028
- BAX PHARMA, s.r.o.
- INTRAVENA s.r.o.
- MED - ART, spol. s r.o.
- PHOENIX Zdravotnícke zásobovanie, a.s.
- UNIPHARMA - 1. slovenská lekárnická akciová spoločnosť
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
1 June 2026
Contract Notice
17 March 2025
Contract Notice
10 February 2025
Contracting authority
Univerzitná nemocnica Martin
Procuring entityMartin, SVK
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.